Endoscope Reprocessing Market

Market Leader - Endoscope Reprocessing Market

The endoscope reprocessing market is projected to reach USD 3.2 billion by 2026 from USD 2.1 billion in 2021, at a CAGR of 9.0% from 2021 to 2026. Endoscope reprocessing involves the cleaning, disinfecting, and sterilization of endoscopes and their accessories. All heat-sensitive endoscopes must be cleaned properly and subjected to high-level disinfectants after each use to prevent the spread of infections. Factors such as increasing preference for endoscopic procedures, high risk of endoscope-associated infections, growing geriatric population and the subsequent increase of endoscopic procedures, and increasing emphasis on improving reprocessing guidelines by healthcare facilities are expected to drive the growth of the market. The Asia Pacific market is estimated to be the fastest-growing regional market, mainly due to the developing healthcare infrastructure in Asian economies, the growing medical tourism industry, and the introduction of innovative products.

The endoscope reprocessing market is highly competitive in nature, with only a few players dominating the overall market. The major players operating in this market are Cantel Medical (US), Advanced Sterilization Products (ASP) (US), Olympus Corporation (Japan), Ecolab (US), STERIS (Ireland), Getinge AB (Sweden), Wassenburg Medical (Netherlands), CONMED Corporation (US), Belimed AG (Switzerland), Endo-Technik W. Griesat (Germany), Custom Ultrasonics (US), Steelco S.p.A. (Italy), BES Healthcare Ltd (UK), ARC Healthcare Solutions (Canada), Metrex Research, LLC. (Canada), Richard Wolf GmbH (Germany), MEDALKAN (Greece), Micro-Scientific, LLC (US), Borer Chemie AG (Switzerland), Tuttnauer (Netherlands), ATMS (Canada), Summit Imaging, Inc. (US), Medonica Co. LTD (South Korea), SHINVA MEDICAL INSTRUMENT CO. LTD (China), and Medical Devices Group Srl (Italy).

To know about the assumptions considered for the study download the pdf brochure

Cantel Medical (US)

Cantel Medical is the leading player in the endoscope reprocessing market, accounting for a share of 17.2% in 2020. Cantel offers a wide range of products in the endoscope reprocessing market through its Medical business segment. The company has advanced products such as the Advantage Plus series of AERs. AERs provide unsurpassed infection control and the lowest cost of ownership. The company holds a large share of the market in terms of efficiency and performance. A strong focus on R&D and new product development helps the company be a frontrunner in innovations and accelerate its revenues. The company also focuses on inorganic growth strategies to strengthen its position in the market. For instance, in 2020, the company entered into a partnership with Censis Technologies. The partnership has combined Cantels leading infection prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis. These activities have helped the company gain a strong foothold in the market.

Advanced Sterilization Products (US)

Advanced Sterilization Products held the second-largest share of 15.8% of the endoscope reprocessing market in 2020. The company offers endoscope reprocessing products such as Automatic Endoscope Reprocessors, detergents/cleaning, and Biocides/High-Level Disinfection. The strong presence of ASP worldwide, covering the Americas, Europe, and the Asia Pacific, helps the firm garner a larger market share. This enables the company to cater to a larger customer base and hence increase its revenue significantly. In addition, the company processed over 187 million test requisitions through its extensive laboratory network in 2020.

Olympus Corporation (Japan)

Olympus Corporation held the third position in the endoscope reprocessing market in 2020. The company has a dedicated business segment that focuses on solutions offered in endoscopy, named Endoscopic Solutions Business. The company has emphasized enhancing its offering to improve the efficiency of its reprocessing systems. In 2018, Olympus invested nearly USD 0.4 Bn (i.e., 4.0 billion) to enhance its systems for performing tests to verify cleaning and disinfection effectiveness. Through this initiative, the company aims to develop systems that would enable the company to swiftly respond to the requirements and challenges faced worldwide due to reprocessing. These advancements made by the company are expected to enable it to hold a strong position in the market.

Related Reports:

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, AER (Portable, Standalone), Endoscope Tracking Solutions, Endoscope Drying, Storage, & Transport Systems), End User (Hospitals, ASCs & Clinics) - Global Forecast to 2026

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
MD 5654
RI Published ON
Choose License Type
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Endoscope Reprocessing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2021 MarketsandMarkets Research Private Ltd. All rights reserved